News Releases

Date Title and Summary Additional Formats
Jan 03, 2019 Oyster Point Pharma to Present at the 37th Annual J.P. Morgan Healthcare Conference
PRINCETON, New Jersey – January 3, 2019 – Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial focus on developing novel therapies for the treatment of Dry Eye Disease, today announced that Jeffrey Nau, M.M.S., Ph.D., President and CEO, is scheduled to
Displaying 11 - 11 of 11